Skip to main content
PMC home page
The BMJ logoLink to The BMJ
. 1995 Nov 18;311(7016):1351–1355. doi: 10.1136/bmj.311.7016.1351

Hepatology.

A N McNair 1, C J Tibbs 1, R Williams 1
PMCID: PMC2551251  PMID: 7496290

Full text

PDF
1352

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. A comparison of tacrolimus (FK 506) and cyclosporine for immunosuppression in liver transplantation. The U.S. Multicenter FK506 Liver Study Group. N Engl J Med. 1994 Oct 27;331(17):1110–1115. doi: 10.1056/NEJM199410273311702. [DOI] [PubMed] [Google Scholar]
  2. Abecassis M., Falk J. A., Makowka L., Dindzans V. J., Falk R. E., Levy G. A. 16, 16 Dimethyl prostaglandin E2 prevents the development of fulminant hepatitis and blocks the induction of monocyte/macrophage procoagulant activity after murine hepatitis virus strain 3 infection. J Clin Invest. 1987 Sep;80(3):881–889. doi: 10.1172/JCI113147. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bernuau J., Goudeau A., Poynard T., Dubois F., Lesage G., Yvonnet B., Degott C., Bezeaud A., Rueff B., Benhamou J. P. Multivariate analysis of prognostic factors in fulminant hepatitis B. Hepatology. 1986 Jul-Aug;6(4):648–651. doi: 10.1002/hep.1840060417. [DOI] [PubMed] [Google Scholar]
  4. Besson I., Ingrand P., Person B., Boutroux D., Heresbach D., Bernard P., Hochain P., Larricq J., Gourlaouen A., Ribard D. Sclerotherapy with or without octreotide for acute variceal bleeding. N Engl J Med. 1995 Aug 31;333(9):555–560. doi: 10.1056/NEJM199508313330904. [DOI] [PubMed] [Google Scholar]
  5. Blei A. T., Olafsson S., Webster S., Levy R. Complications of intracranial pressure monitoring in fulminant hepatic failure. Lancet. 1993 Jan 16;341(8838):157–158. doi: 10.1016/0140-6736(93)90016-a. [DOI] [PubMed] [Google Scholar]
  6. Boudjema K., Cherqui D., Jaeck D., Chenard-Neu M. P., Steib A., Freis G., Becmeur F., Brunot B., Simeoni U., Bellocq J. P. Auxiliary liver transplantation for fulminant and subfulminant hepatic failure. Transplantation. 1995 Jan 27;59(2):218–223. [PubMed] [Google Scholar]
  7. Brillanti S., Garson J., Foli M., Whitby K., Deaville R., Masci C., Miglioli M., Barbara L. A pilot study of combination therapy with ribavirin plus interferon alfa for interferon alfa-resistant chronic hepatitis C. Gastroenterology. 1994 Sep;107(3):812–817. doi: 10.1016/0016-5085(94)90131-7. [DOI] [PubMed] [Google Scholar]
  8. Chemello L., Cavalletto L., Noventa F., Bonetti P., Casarin C., Bernardinello E., Pontisso P., Donada C., Casarin P., Belussi F. Predictors of sustained response, relapse and no response in patients with chronic hepatitis C treated with interferon-alpha. J Viral Hepat. 1995;2(2):91–96. doi: 10.1111/j.1365-2893.1995.tb00012.x. [DOI] [PubMed] [Google Scholar]
  9. Conn H. O., Grace N. D., Bosch J., Groszmann R. J., Rodés J., Wright S. C., Matloff D. S., Garcia-Tsao G., Fisher R. L., Navasa M. Propranolol in the prevention of the first hemorrhage from esophagogastric varices: A multicenter, randomized clinical trial. The Boston-New Haven-Barcelona Portal Hypertension Study Group. Hepatology. 1991 May;13(5):902–912. [PubMed] [Google Scholar]
  10. Donahue J. G., Muñoz A., Ness P. M., Brown D. E., Jr, Yawn D. H., McAllister H. A., Jr, Reitz B. A., Nelson K. E. The declining risk of post-transfusion hepatitis C virus infection. N Engl J Med. 1992 Aug 6;327(6):369–373. doi: 10.1056/NEJM199208063270601. [DOI] [PubMed] [Google Scholar]
  11. Gimson A. E., Ramage J. K., Panos M. Z., Hayllar K., Harrison P. M., Williams R., Westaby D. Randomised trial of variceal banding ligation versus injection sclerotherapy for bleeding oesophageal varices. Lancet. 1993 Aug 14;342(8868):391–394. doi: 10.1016/0140-6736(93)92812-8. [DOI] [PubMed] [Google Scholar]
  12. González A., Esteban J. I., Madoz P., Viladomiu L., Genesca J., Muñiz E., Enríquez J., Torras X., Hernández J. M., Quer J. Efficacy of screening donors for antibodies to the hepatitis C virus to prevent transfusion-associated hepatitis: final report of a prospective trial. Hepatology. 1995 Aug;22(2):439–445. doi: 10.1002/hep.1840220211. [DOI] [PubMed] [Google Scholar]
  13. Hamasaki K., Nakata K., Nagayama Y., Ohtsuru A., Daikoku M., Taniguchi K., Tsutsumi T., Sato Y., Kato Y., Nagataki S. Changes in the prevalence of HBeAg-negative mutant hepatitis B virus during the course of chronic hepatitis B. Hepatology. 1994 Jul;20(1 Pt 1):8–14. doi: 10.1016/0270-9139(94)90127-9. [DOI] [PubMed] [Google Scholar]
  14. Harrison P. M., Keays R., Bray G. P., Alexander G. J., Williams R. Improved outcome of paracetamol-induced fulminant hepatic failure by late administration of acetylcysteine. Lancet. 1990 Jun 30;335(8705):1572–1573. doi: 10.1016/0140-6736(90)91388-q. [DOI] [PubMed] [Google Scholar]
  15. Harrison P. M., Wendon J. A., Gimson A. E., Alexander G. J., Williams R. Improvement by acetylcysteine of hemodynamics and oxygen transport in fulminant hepatic failure. N Engl J Med. 1991 Jun 27;324(26):1852–1857. doi: 10.1056/NEJM199106273242604. [DOI] [PubMed] [Google Scholar]
  16. Hayes P. C., Davis J. M., Lewis J. A., Bouchier I. A. Meta-analysis of value of propranolol in prevention of variceal haemorrhage. Lancet. 1990 Jul 21;336(8708):153–156. doi: 10.1016/0140-6736(90)91668-z. [DOI] [PubMed] [Google Scholar]
  17. Laine L., el-Newihi H. M., Migikovsky B., Sloane R., Garcia F. Endoscopic ligation compared with sclerotherapy for the treatment of bleeding esophageal varices. Ann Intern Med. 1993 Jul 1;119(1):1–7. doi: 10.7326/0003-4819-119-1-199307010-00001. [DOI] [PubMed] [Google Scholar]
  18. McOmish F., Yap P. L., Dow B. C., Follett E. A., Seed C., Keller A. J., Cobain T. J., Krusius T., Kolho E., Naukkarinen R. Geographical distribution of hepatitis C virus genotypes in blood donors: an international collaborative survey. J Clin Microbiol. 1994 Apr;32(4):884–892. doi: 10.1128/jcm.32.4.884-892.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Noda Y., Hughes R. D., Williams R. Effect of prostacyclin (PGI2) and a prostaglandin analogue BW 245C on galactosamine-induced hepatic necrosis. J Hepatol. 1986;2(1):53–64. doi: 10.1016/s0168-8278(86)80008-3. [DOI] [PubMed] [Google Scholar]
  20. O'Grady J. G., Alexander G. J., Hayllar K. M., Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology. 1989 Aug;97(2):439–445. doi: 10.1016/0016-5085(89)90081-4. [DOI] [PubMed] [Google Scholar]
  21. O'Grady J. G., Schalm S. W., Williams R. Acute liver failure: redefining the syndromes. Lancet. 1993 Jul 31;342(8866):273–275. doi: 10.1016/0140-6736(93)91818-7. [DOI] [PubMed] [Google Scholar]
  22. Poynard T., Bedossa P., Chevallier M., Mathurin P., Lemonnier C., Trepo C., Couzigou P., Payen J. L., Sajus M., Costa J. M. A comparison of three interferon alfa-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. Multicenter Study Group. N Engl J Med. 1995 Jun 1;332(22):1457–1462. doi: 10.1056/NEJM199506013322201. [DOI] [PubMed] [Google Scholar]
  23. Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection. European FK506 Multicentre Liver Study Group. Lancet. 1994 Aug 13;344(8920):423–428. [PubMed] [Google Scholar]
  24. Rolando N., Gimson A., Wade J., Philpott-Howard J., Casewell M., Williams R. Prospective controlled trial of selective parenteral and enteral antimicrobial regimen in fulminant liver failure. Hepatology. 1993 Feb;17(2):196–201. [PubMed] [Google Scholar]
  25. Rolles K., Burroughs A. K., Davidson B. R., Karatapanis S., Prentice H. G., Hamon M. D. Donor-specific bone marrow infusion after orthotopic liver transplantation. Lancet. 1994 Jan 29;343(8892):263–265. doi: 10.1016/s0140-6736(94)91113-4. [DOI] [PubMed] [Google Scholar]
  26. Rozga J., Williams F., Ro M. S., Neuzil D. F., Giorgio T. D., Backfisch G., Moscioni A. D., Hakim R., Demetriou A. A. Development of a bioartificial liver: properties and function of a hollow-fiber module inoculated with liver cells. Hepatology. 1993 Feb;17(2):258–265. [PubMed] [Google Scholar]
  27. Salmerón J. M., Titó L., Rimola A., Mas A., Navasa M. A., Llach J., Ginès A., Ginès P., Arroyo V., Rodés J. Selective intestinal decontamination in the prevention of bacterial infection in patients with acute liver failure. J Hepatol. 1992 Mar;14(2-3):280–285. doi: 10.1016/0168-8278(92)90171-k. [DOI] [PubMed] [Google Scholar]
  28. Schaluder G. G., Dawson G. J., Simons J. N., Pilot-Matias T. J., Gutierrez R. A., Heynen C. A., Knigge M. F., Kurpiewski G. S., Buijk S. L., Leary T. P. Molecular and serologic analysis in the transmission of the GB hepatitis agents. J Med Virol. 1995 May;46(1):81–90. doi: 10.1002/jmv.1890460117. [DOI] [PubMed] [Google Scholar]
  29. Sekiyama K., Yoshiba M., Inoue K., Sugata F. Prognostic value of hepatic volumetry in fulminant hepatic failure. Dig Dis Sci. 1994 Feb;39(2):240–244. doi: 10.1007/BF02090192. [DOI] [PubMed] [Google Scholar]
  30. Silini E., Bono F., Cividini A., Cerino A., Maccabruni A., Tinelli C., Bruno S., Bellobuono A., Mondelli M. Molecular epidemiology of hepatitis C virus infection among intravenous drug users. J Hepatol. 1995 Jun;22(6):691–695. doi: 10.1016/0168-8278(95)80225-8. [DOI] [PubMed] [Google Scholar]
  31. Simmonds P., Alberti A., Alter H. J., Bonino F., Bradley D. W., Brechot C., Brouwer J. T., Chan S. W., Chayama K., Chen D. S. A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology. 1994 May;19(5):1321–1324. [PubMed] [Google Scholar]
  32. Simons J. N., Pilot-Matias T. J., Leary T. P., Dawson G. J., Desai S. M., Schlauder G. G., Muerhoff A. S., Erker J. C., Buijk S. L., Chalmers M. L. Identification of two flavivirus-like genomes in the GB hepatitis agent. Proc Natl Acad Sci U S A. 1995 Apr 11;92(8):3401–3405. doi: 10.1073/pnas.92.8.3401. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Steffen R., Kane M. A., Shapiro C. N., Billo N., Schoellhorn K. J., van Damme P. Epidemiology and prevention of hepatitis A in travelers. JAMA. 1994 Sep 21;272(11):885–889. [PubMed] [Google Scholar]
  34. Stiegmann G. V., Goff J. S., Michaletz-Onody P. A., Korula J., Lieberman D., Saeed Z. A., Reveille R. M., Sun J. H., Lowenstein S. R. Endoscopic sclerotherapy as compared with endoscopic ligation for bleeding esophageal varices. N Engl J Med. 1992 Jun 4;326(23):1527–1532. doi: 10.1056/NEJM199206043262304. [DOI] [PubMed] [Google Scholar]
  35. Sung J. J., Chung S. C., Lai C. W., Chan F. K., Leung J. W., Yung M. Y., Kassianides C., Li A. K. Octreotide infusion or emergency sclerotherapy for variceal haemorrhage. Lancet. 1993 Sep 11;342(8872):637–641. doi: 10.1016/0140-6736(93)91758-e. [DOI] [PubMed] [Google Scholar]
  36. Sussman N. L., Chong M. G., Koussayer T., He D. E., Shang T. A., Whisennand H. H., Kelly J. H. Reversal of fulminant hepatic failure using an extracorporeal liver assist device. Hepatology. 1992 Jul;16(1):60–65. doi: 10.1002/hep.1840160112. [DOI] [PubMed] [Google Scholar]
  37. Sussman N. L., Gislason G. T., Conlin C. A., Kelly J. H. The Hepatix extracorporeal liver assist device: initial clinical experience. Artif Organs. 1994 May;18(5):390–396. doi: 10.1111/j.1525-1594.1994.tb02221.x. [DOI] [PubMed] [Google Scholar]
  38. Valdivieso V., Covarrubias C., Siegel F., Cruz F. Pregnancy and cholelithiasis: pathogenesis and natural course of gallstones diagnosed in early puerperium. Hepatology. 1993 Jan;17(1):1–4. [PubMed] [Google Scholar]
  39. Whitington P. F., Emond J. C., Heffron T., Thistlethwaite J. R. Orthotopic auxiliary liver transplantation for Crigler-Najjar syndrome type 1. Lancet. 1993 Sep 25;342(8874):779–780. doi: 10.1016/0140-6736(93)91543-u. [DOI] [PubMed] [Google Scholar]
  40. Whittle H. C., Maine N., Pilkington J., Mendy M., Fortuin M., Bunn J., Allison L., Howard C., Hall A. Long-term efficacy of continuing hepatitis B vaccination in infancy in two Gambian villages. Lancet. 1995 Apr 29;345(8957):1089–1092. doi: 10.1016/s0140-6736(95)90822-6. [DOI] [PubMed] [Google Scholar]
  41. Yuki N., Hayashi N., Kasahara A., Hagiwara H., Takehara T., Oshita M., Katayama K., Fusamoto H., Kamada T. Pretreatment viral load and response to prolonged interferon-alpha course for chronic hepatitis C. J Hepatol. 1995 Apr;22(4):457–463. doi: 10.1016/0168-8278(95)80109-x. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES